1 documents found
Information × Registration Number 0119U102924, R & D request Title A randomized, double-blind, placebo-controlled, 2-phase clinical trial aimed at assessing the safety and efficacy of GL0817 (when used with cyclophosphamide) for the prevention of disease recurrence in HLA-A2 positive patients with squamous cell carcinoma cell carcinoma Head Chornobai Anatolii V., Registration Date 27-08-2019 Organization Ukrainian medical stomatological Academy popup.description1 Study of the safety and efficacy of GL0817 (when used with cyclophosphamide) for the prevention of disease recurrence in HLA-A2 positive patients with high-risk squamous cell carcinoma popup.nrat_date 2024-12-10 Close
search.res_rk
A randomized, double-blind, placebo-controlled, 2-phase clinical trial aimed at assessing the safety and efficacy of GL0817 (when used with cyclophosphamide) for the prevention of disease recurrence in HLA-A2 positive patients with squamous cell carcinoma cell carcinoma
Head: Chornobai Anatolii V.. A randomized, double-blind, placebo-controlled, 2-phase clinical trial aimed at assessing the safety and efficacy of GL0817 (when used with cyclophosphamide) for the prevention of disease recurrence in HLA-A2 positive patients with squamous cell carcinoma cell carcinoma. Ukrainian medical stomatological Academy. № 0119U102924
1 documents found

Updated: 2026-03-19


Роздрукувати цю сторінку